Amerikanische Gesellschaft für Hirudotherapie

Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants

Research article published in Molecules (Basel, Switzerland) (2019)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportKlinische StudienSicherheit & InfektionskontrolleMendes A et al. · Molecules (Basel, Switzerland), 2019

Abstract

Nowadays, pharmaceutical heparin is purified from porcine and bovine intestinal mucosa. In the past decade there has been an ongoing concern about the safety of heparin, since in 2008, adverse effects associated with the presence of an oversulfated chondroitin sulfate (OSCS) were observed in preparations of pharmaceutical porcine heparin, which led to the death of patients, causing a global public health crisis. However, it has not been clarified whether OSCS has been added to the purified heparin preparation, or whether it has already been introduced during the production of the raw heparin. Using a combination of different analytical methods, we investigate both crude and final heparin products and we are able to demonstrate that the sulfated contaminants are intentionally introduced in the initial steps of heparin preparation. Furthermore, the results show that the oversulfated compounds are not structurally homogeneous. In addition, we show that these contaminants are able to bind to cells in using well known heparin binding sites. Together, the data highlights the importance of heparin quality control even at the initial stages of its production.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsAnticoagulantsCattleChondroitin SulfatesDrug ContaminationHeparinHeparin LyaseHumansHydrolysisIntestinal MucosaMagnetic Resonance SpectroscopyPolysaccharide-Lyases

Zusammenfassung

Nowadays, pharmaceutical heparin is purified from porcine and bovine intestinal mucosa.

Warum dies für die Hirudotherapie relevant ist

This study analyzed crude and final pharmaceutical heparin products to trace the origins of structurally diverse oversulfated contaminants, such as oversulfated chondroitin sulfate (OSCS), which previously caused adverse health events. The research is entirely focused on the quality control, manufacturing processes, and cellular binding properties of heparin derived from porcine and bovine intestinal mucosa. It holds no relevance to the American Society of Hirudotherapy, as it does not involve leeches, hirudotherapy, or leech-derived anticoagulants like hirudin. Consequently, the article provides no applicable insights for the society's research library.

Zitation

Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants

Mendes A et al. · Molecules (Basel, Switzerland), 2019

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.